OTC Markets OTCPK - Delayed Quote USD
Innate Pharma S.A. (IPHYF)
1.4500
-0.3100
(-17.61%)
At close: April 11 at 3:59:50 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 5 | 4 |
| Avg. Estimate | -- | -- | 92.06M | 128.31M |
| Low Estimate | -- | -- | 12.94M | 6.75M |
| High Estimate | -- | -- | 184M | 288M |
| Year Ago Sales | -- | -- | 20.12M | 92.06M |
| Sales Growth (year/est) | -- | -- | 357.55% | 39.37% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IPHYF | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Related Tickers
0PT.F Prothena Corporation plc
4.0600
+1.50%
FYB.SG Formycon AG
26.25
+3.96%
5NRA.MU Nanobiotix SA
3.7400
+2.75%
9VC.F Atai Life Sciences N.V.
2.1520
+1.03%
ALCLS.PA Cellectis S.A.
1.3300
-0.60%
FYB.F Formycon AG
26.20
+3.97%
PHXM.PA PHAXIAM Therapeutics S.A.
0.2000
-0.50%
RGO.SG Regeneron Pharmaceuticals Inc
435.40
-0.23%
NANO.PA Nanobiotix S.A.
4.0100
+7.65%
GNFT.PA Genfit S.A.
3.9200
-1.56%